We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report for the 6 months to 31 Dec 2023

19 Feb 2024 07:30

RNS Number : 5882D
Sabien Technology Group PLC
19 February 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

19 February 2024

Sabien Technology Group Plc

("Sabien", the "Company" or the "Group")

 

Unaudited Interim Results for the six months ended 31 December 2023

 

Sabien Technology Group plc (AIM: SNT), the company focused on a green aggregation strategy, today announces its unaudited interim results for the six-month period ended 31 December 2023 (the "Period"). Comparative figures are shown for the comparable period in the previous financial year unless otherwise stated:

 

Financial highlights

 

6 months to 31 December 2023

6 months to 31 December 2022

Year to

30 June

2023

Unaudited

Unaudited

Audited

Sales revenue

£'000

369

238

1,098

Sales orders received

£'000

386

212

1,136

Sales invoices raised

£'000

320

189

1,118

Gross profit margin

%

62

51

64

Net loss after tax

£'000

(371)

(437)

(702)

Cash at end of period

£'000

176

354

436

 

Executive Chairman's Statement

It is very pleasing to report interim results which so clearly demonstrate progress. Revenue growth of 55% highlights the success of M2G in both raising awareness and innovating within its core product suite. That this translated into an 88.4% improvement in gross profit validates this strategy. The 82% increase in orders received underpins my confidence in further growth.

 

This confidence extends to the development of b.grn. Our recent progress in the US has brought the generation of a positive return much closer. Like M2G before it, b.grn's concept requires wider awareness of the benefits in order to secure its growth. I am in no doubt that such awareness is more likely to be achieved within US markets and that US awareness will drive adoption in Europe. 

 

 

M2G Business

M2G has continued to outperform its KPIs through the first half of the current financial year. Specifically, it has achieved significant progress in raising awareness of its products' benefits within a disparate range of customers. The consequent growth in sales, billings, and orders is a testament to both M2G's concept and its ability to innovate within this space.

 

M2G Cloud Connect has assisted customers in saving 1.41 million KgCO2 in just one year. As Cloud Connect is rolled out to US markets, it is expected that these savings will increase further. M2G Evo is in the final stages of development and is on the verge of CE and UL testing, the successful conclusion of which will allow a wide launch. In addition, M2G Evo will allow Sabien to access additional supply chains due to the use of common components. This should reduce the cost of the product, thereby increasing gross margin.

 

For the six months ended 31 December 2023, Sabien recognised M2G revenue of £0.37m, an increase of over 1.5x on the comparative period (£0.24m). To 16 February 2024, Sabien has received orders in excess of £0.50m, an increase of over 2x on the comparative period (£0.25m); and has invoiced £0.35m, an increase of over 1.3x on the prior year (£0.27m). Recent orders include an order from a new channel partner of £0.07m.

 

COF / b.grn Business

Sabien confirms that its affiliate company, b.grn Group Limited ("b.grn"), is participating in a consortium of green energy and sustainability companies to establish a resource cluster within a large, fast growing, environmentally conscious, US city (the "City") which has approved this announcement. A Mayor-led initiative established a global competition process more than two years ago, and the successful responding group was selected in late December 2023. Under this initiative, through an agreement with the project developer, b.grn will have the potential to construct and operate the first US-based installation of COF technology on a site leased from the City. The installation will process plastic waste both provided by the City and sourced from private enterprises. b.grn envisions that the offtake products from the proposed plant will be consumed within the City. 

 

It is anticipated that this project, which is expected to be announced by the City no later than Q3 of 2024, will attract significant funding and will be a blueprint for wider technology adoption in the US and internationally. Under existing contracts, Sabien will benefit for both sales commissions on the supply of equipment to the project and a share of operational profits generated by b.grn.

 

To drive the successful launch of this project the services of a circular economy industry leader and former public company CEO have been secured to lead negotiations with the City. An LOI/MOU detailing high level business terms between the City, b.grn and other consortium members is likely to be signed and announced in the next Quarter with an established contract or contracts to be signed and announced no later than Q4 2024. It is likely Sabien will need to invest in the initial administrative enablement of this project to ensure the necessary external development funding is secured.

 

Proton Technologies Canada Inc. and Aeristech investment

Sabien is not focusing on these partners currently and there is no further update since the 2023 annual report.

 

 

Parris Group Loan

Sabien currently has a funding requirement to bridge the timing of the significant M2G order conversion into revenue, as well as requirements to complete the M2G Evo development and continue with the COF/b.grn project.

 

To fund this requirement, my family company, Parris Group Limited ("PGL"), has made a £0.2m debt facility available to Sabien.

 

The loan facility (the "New Loan") follows a previous PGL 12-month arrangement, announced in March 2022, for £209,302.33, of which £5,135 including accrued interest remained outstanding as at 31 December 2023.

 

The key terms of the New Loan are as follows:

 

· Up to £200,000;

· Interest rate of 12% per annum;

· Interest payable quarterly;

· Repayable by agreement with the Sabien board of directors for an initial period of 12 months unless replaced by another debt facility, afterwards on demand; and

· Unsecured.

 

Summary

Against a turbulent background, Sabien has made considerable positive progress in the first half of the current financial year. It has delivered and developed such that further progress is more likely.

 

M2G has exceeded expectations; generating revenue at lower cost, winning orders across geographies, and innovating within its product suite. b.grn has achieved another milestone in its development trajectory. The expected signing of terms with a US city will bring revenue generation closer and provide a high-profile platform from which to raise awareness and adoption elsewhere. 

 

I have argued that Sabien's development will not be linear. I remain of this view, but I am now more confident that our businesses' growth prospects are not dependent on the economic environment. Our challenge is to raise awareness and having done so, to deploy successfully.

 

The scale and scope of our development is in our hands. I believe that we have demonstrated this ability in our first half results. I am confident that it will remain the case and that further growth is in prospect.

 

Richard Parris

Executive Chairman

19 February 2024

 

Related Party Transaction

 

Parris Group Ltd is a Company controlled by Richard Parris, the Executive Chairman of the Company, and his family. The Board, other than Mr Parris, considers, having consulted with Allenby Capital Limited, the Company's nominated adviser, that the terms of the New Loan are fair and reasonable insofar as its shareholders are concerned.

 

For further information:

 

Sabien Technology Group plc

Richard Parris, Executive Chairman 

Scott Fulton, Investor Relations 

 

+44 20 7993 3700

Scott.fulton@sabien.com 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

 

+44 203 328 5656

 

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams 

 

+44 207 469 0930

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Comprehensive Income for the period ended 31 December 2023

 

Notes

6 months to 31 December 2023

6 months to 31 December 2022

Year to

30

June

2023

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Revenue

369

238

1,098

Cost of Sales

(141)

(117)

(394)

Gross Profit

228

121

704

Administrative expenses

(597)

(676)

(1,331)

Exceptional item

-

-

-

 

 

 

 

 

Operating loss

 

(369)

(555)

(627)

Other income

-

100

1

Finance cost

(4)

(3)

(7)

Finance income

2

-

3

Impairment loss

-

-

(99)

Loss before tax

(371)

(458)

(729)

Tax credit

-

21

27

Loss for the period attributable to equity holders of the parent company

(371)

(437)

(702)

 

 

 

 

Other comprehensive income for the period

-

-

-

 

Total comprehensive income for the period

 

(371)

(437)

(702)

 

 

 

 

 

Loss per share in pence - basic

3

(1.71)p

(2.12)p

(3.59)p

Loss per share in pence - diluted

3

(1.71)p

(2.12)p

(3.59)p

 

 

 

 

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Financial Position as at 31 December 2023

 

Notes

31 December 2023

31 December 2022

 30 June

 2023

Unaudited

Unaudited

Audited

£'000

£'000

£'000

ASSETS

Non-current assets

Property, plant and equipment

1

2

1

Other intangible assets

155

126

112

Investments

382

300

382

Total non-current assets

538

428

495

Current assets

Inventories

114

45

79

Trade and other receivables

37

454

202

Cash and cash equivalents

176

354

436

Total current assets

327

853

717

TOTAL ASSETS

865

1,281

1,212

 

 

 

 

EQUITY AND LIABILITIES

Current liabilities

Trade and other payables

542

289

500

Borrowings

39

39

39

Total current liabilities

581

328

539

Non-current liabilities

Borrowings

54

91

72

Total non-current liabilities

54

91

72

EQUITY

 

 

 

 

Equity attributable to equity holders of the parent

Share capital

4

3,563

3,563

3,563

Other reserves

4,018

4,014

4,018

Retained earnings

(7,351)

(6,715)

(6,980)

Total equity

230

862

601

TOTAL EQUITY AND LIABILITIES

 

865

1,281

1,212

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Cash Flow Statement for the period ended 31 December 2023

 

6 months

to

31 December 2022

6 months

to

31 December 2022

Year

to

30 June

 2023

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Cash flows from operating activities

Loss after taxation

(371)

(437)

(702)

Adjustments for:

Depreciation and amortisation

31

31

64

Impairment loss on investments

-

-

99

Foreign currency reserve movement

1

5

6

Taxation

-

(21)

(27)

Finance cost

4

3

7

Less movement in interest accrual

-

(2)

(1)

Decrease / (increase) in trade and other receivables

166

(62)

29

Increase in inventories

(35)

(4)

(39)

Increase / (decrease) in trade and other payables

40

(207)

12

Net cash outflow from operating activities

(164)

(694)

(552)

 

Cash flows from investing activities

Investments acquired

-

(100)

(89)

Purchase of intangible assets

(74)

(6)

(24)

Loan advance to associated undertaking

-

-

(37)

Research and development corporation tax refund

-

-

27

 

Net cash used in investing activities

(74)

(106)

(123)

Cash flows from financing activities

Repayment of borrowings

(18)

(18)

(36)

Interest paid

(4)

(2)

(6)

Proceeds from share issues

-

600

600

Share issue costs

(20)

(20)

Net cash (used in) / generated by financing activities

(22)

581

538

Net decrease in cash and cash equivalents

(260)

(219)

(137)

Cash and cash equivalents at beginning of period

436

573

573

Cash and cash equivalents at end of period

176

354

436

 

Sabien Technology Group Plc

 

Unaudited Condensed Group Statement of Changes in Equity as at 31 December 2022

 

Share capital

Share premium

Other reserves

Retained earnings

Total equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 July 2022

3,354

3,543

1

(6,278)

620

 

Loss for the period

1 July 2022 to

31 December 2022

-

-

-

(437)

(437)

Share issue

209

488

-

-

677

Share issue costs

-

(20)

 

Foreign exchange variance

-

-

2

-

2

 

Balance at 31 December 2022

3,563

4,011

3

(6,715)

862

 

 

 

 

 

 

 

Loss for the period

1 January 2023 to 30 June 2023

-

-

-

(265)

(265)

Warrants lapsed

-

10

(10)

-

-

Foreign exchange variance

-

-

4

-

4

 

Balance at 30 June 2023

3,563

4,021

(3)

(6,980)

601

 

Loss for the period

1 July 2023 to

31 December 2023

-

-

-

(371)

(371)

 

Balance at 31 December 2023

3,563

4,021

(3)

(7,351)

230

 

 

 

Sabien Technology Group Plc

 

Notes to the Financial Statements for the period ended 31 December 2023

 

1. Accounting policies

 

The interim financial information has not been audited or reviewed by the auditors and does not constitute statutory accounts for the purpose of Sections 434 and 435 of the Companies Act 2006.

 

The financial information in this document has been prepared using accounting principles generally accepted under International Financial Reporting Standards and is consistent with those used in the preparation of the most recent annual financial statements.

 

These interim financial statements for the six-month period ended 31 December 2023 have been prepared using the historical cost convention, on a going concern basis and in accordance with applicable UK adopted International Financial Reporting Standards.

 

The financial statements for the year ended 30 June 2023 have been delivered to the Registrar of Companies and filed at Companies House and the auditors' report on those financial statements was unqualified. The auditors' report did not contain a statement made under Section 498(2) or Section 498(3) of the Companies Act 2006.

 

2. Segmental reporting

 

Based on risks and returns, the directors consider that the primary reporting business format is by business segment which is currently just the supply of energy efficiency products, as this forms the basis of internal reports that are regularly reviewed by the Company's chief operating decision maker in order to allocate resources to the segment and assess its performance. Therefore, the disclosures for the primary segment have already been given in interim financial information. The secondary reporting format is by geographical analysis by destination. Non-UK revenues amounted to £2k which were less than 1% of total revenues for the period.

 

During the period, sales to the Group's largest customers were as follows:

 

Sales revenue

% of total revenue

£'000

 

Customer 1

196

53

Customer 2

47

13

Customer 3

31

8

Customer 4

18

5

 

 

 

3. Loss per share

 

The calculation of the basic loss per share is based on the loss attributable to the ordinary shareholders, divided by the weighted average number of shares in issue in the period.

6 months to 31 December 2023

6 months to 31 December 2022

Year to

 30

 June

 2023

Unaudited

Unaudited

Audited

£'000

£'000

£'000

 

Loss for the period

 

(371)

 

(535)

 

(702)

Basic and Diluted:

Weighted average number of shares in issue

21,695,168

20,532,668

20,651,081

Loss per share - basic and diluted

(1.71)p

(2.12)p

(3.59)p

 

 

 

 

4. Share capital

 

The Company's issued Ordinary share capital is:

Amount

£'000

No. of New Ordinary Shares of 3p each

No. of Deferred Shares of 4.5p each

No. of New Deferred Shares of 0.49p each

Allotted, called up and fully paid:

At 31 December 2023

3,563

21,695,168

44,004,867

190,254,867

At 30 June 2023

3,363

21,695,168

44,004,867

190,254,867

At 31 December 2022

3,563

21,695,168

44,004,867

190,254,867

 

 

 

5. Share options and warrants

 

At the period end date, the following options had been granted:

 

Grant date

Number of instruments

Exercise price

Contractual life of instruments

 

 

 

31 October 2014

117

£163.5

October 2024

 

At the period end date, there were no warrants outstanding (31 December 2022: 1,675,349, 30 June 2023: nil).

 

In February 2023, 1,675,349 outstanding warrants expired.

 

6. Seasonality

 

The business of the Group is not seasonal.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKLBFZLLLBBD
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.